PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C
February 2001
Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C.
PEG-Intron is the first "pegylated" interferon.
It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon and makes it longer-acting.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote